Study of malarial chemoprophylaxis and pregnancy gingivitis in Nigerian women

S A Ogunwande1

  • 1Atinike Dental Hospital, Osogbo, Nigeria.

Clinical Preventive Dentistry
|September 1, 1991
PubMed

Resolution of pregnancy gingivitis during pregnancy despite the usual therapy of scaling has not proved to be satisfactory. A clinical study of pregnancy gingivitis in 55 pregnant women (23 primigravid, 32 multigravid) showed pyrimethamine prophylaxis had a significant positive effect in the resolution of gingivitis during pregnancy. At the end of the gestation period, pregnant women who received pyrimethamine as malarial chemoprophylaxis showed significant improvements, as compared with placebo, in relation to gingival bleeding and enlargement, whether primigravid or multigravid. These clinical observations suggest that pyrimethamine may exhibit properties that may be inflammatory, act as immune enhancer and antihyperplastic agent by probably possessing an antagonistic effect upon nucleic acid synthesis.

Related Concept Videos

Development of the Oral Microbiota01:28

Development of the Oral Microbiota

The establishment of the oral microbiome begins before birth, challenging the long-held belief that the fetal oral cavity is sterile. The presence of oral microbes such as Streptococcus and Fusobacterium in amniotic fluid suggests that microbial exposure may occur in utero, potentially through translocation from the maternal oral or gastrointestinal tract. This early colonization primes the neonatal immune system and sets the stage for subsequent microbial succession. Maternal health,...
Malaria01:29

Malaria

Malaria pathogenesis in humans reflects a delicate interplay between parasite biology and host response. Clinical illness reflects a host’s immune response to the parasite’s asexual replication cycle, which is often asymptomatic in individuals with partial immunity. From the parasite's perspective, transmission between mosquito and human with minimal host pathology is evolutionarily advantageous. Among the six Plasmodium species infecting humans, P. falciparum and P. vivax dominate in global...
Antiprotozoal Agents01:21

Antiprotozoal Agents

Leishmaniasis is a widespread parasitic disease caused by several Leishmania species. It affects millions of people each year and remains a major public health problem in endemic regions. First-line treatment relies on pentavalent antimonials, including meglumine antimoniate and sodium stibogluconate. Even so, how these drugs work has not been fully clear, especially their interaction with parasite-specific biochemical pathways. One key target is trypanothione reductase (TR), an enzyme that...